Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin-1 stimulatory effects

FEBS Letters

Volumn 451, Issue 1, 1999, Pages 63-67

  El Mowafy, Abdalla M ^a   White, Richard E ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Coronary artery; Endothelin 1; Mitogen activated protein kinase; Nuclear translocation; Resveratrol; Vascular smooth muscle

Indexed keywords

ENDOTHELIN 1; FORSKOLIN; FULVESTRANT; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; QUERCETIN; RESVERATROL; TAMOXIFEN;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; ENZYME ACTIVITY; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SWINE;

ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL NUCLEUS; CORONARY VESSELS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIN-1; ENZYME INHIBITORS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; STILBENES; SWINE; TYROSINE;

SUIDAE;

EID: 0032911668     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00541-4     Document Type: Article

References (44)

1. Kopp P. Eur. J. Endocrinol. 138:1998;619-620.
2. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Science. 275:1997;218-220.
3. Mgbonyebi O.P., Russo J., Russo I. Int. J. Oncol. 12:1998;865-869.
4. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. FEBS Lett. 421:1998;277-279.
5. Ragione F.D., Cucciolla V., Borriello A., Pietra V.D., Racioppi L., Soldati G., Manna C., Galletti P., Zappia V. Biochem. Biophys. Res. Commun. 250:1998;53-58.
6. Kimura Y., Okuda H., Kubo M. J. Ethnopharmacol. 45:1995;131-139.
7. Fitzpatrick D.F., Hirschfield S.L., Coffey R.G. Am. J. Physiol. 265:1993;H774-778.
8. Chen C.K., Asciak C.R. Gen. Pharmacol. 27:1996;263-266.
9. Sargent C.A., Liu E.C., Chao C.C., Monshizadegan H., Webb M.L., Grover G.J. Life Sci. 55:1994;1833-1844.
10. Tinnessen T., Giaid A., Saleh D., Naess P.A., Yanagisawa M., Christensen G. Circ. Res. 76:1995;767-772.
11. Hoffmann E., Assennato P., Donatelli M., Colletti I., Valenti T.M. Am. Heart J. 135:1998;684-688.
12. El-Mowafy A.M., White R.E. Biochem. Biophys. Res. Commun. 251:1998;494-500.
13. Pernow J., Wang Q.D. Cardiovasc. Res. 33:1997;518-526.
14. Webb D.J., Monge J.C., Rabelink T.J., Yanagisawa M. Trends Pharmacol. Sci., 19:1998;5-8.
15. Rubanyi G.M., Polokoff M.A. Pharmacol. Rev. 46:1994;325-415.
16. De Silva H., Cioffi C., Yin T., Sandhu G., Webb R.L., Whelan J. Biochem. Biophys. Res. Commun. 250:1998;647-652.
17. Davis R.D. Trends Biochem. Sci. 19:1994;470-473.
18. Knight R.J., Buxton D.B. Biochem. Biophys. Res. Commun. 218:1996;83-88.
19. Gille H., Sharrocks A.D., Shaw P.E. Nature. 358:1992;414-417.
20. Cavigelli M., Dolfi F., Claret F.X., Karin M. EMBO J. 14:1995;5957-5964.
21. Jin N., Siddiqu R.A., English D., Rhoades R.A. Am. J. Physiol. 271:1996;H1348-1355.
22. Florian J.A., Watts S.W. J. Pharmacol. Exp. Ther. 284:1998;346-355.
23. Mizukami Y., Yoshioka K., Morimoto S. J. Biol. Chem. 272:1997;16657-16662.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R. J. Biol. Chem. 193:1951;265-275.
25. Laemmli U.K. Nature. 227:1970;680-685.
26. Soleas G.J., Diamandis E.P., Goldberg D.M. Clin. Biochem. 30:1997;91-113.
27. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Proc. Natl. Acad. Sci. USA. 94:1997;14138-14143.
28. Darkow D.J., Lu L., White R.E. Am. J. Physiol. 272:1997;H2765-2773.
29. Morey A., Pedram A., Razandi M., Prins B., Hu R., Biesiada E., Levin E. Endocrinology. 138:1997;3330-3339.
30. Mügge A., Riedel M., Barton M., Kuhn M., Lichtlen P.R. Cardiovasc. Res. 27:1993;1939-1942.
31. Vargas R., Wroblewska B., Hatch R.A., Ramwell P.W. Br. J. Pharmacol. 109:1993;612-617.
32. Cook S.J., McCormick F. Science. 262:1993;1069-1072.
33. Wu J., Dent P., Jelinek T., Wolfman A., Weber M.J., Sturgill T.W. Science. 262:1993;1065-1069.
34. Chen Z.-J., Yu L., Chang C.-H. Biochem. Biophys. Res. Commun. 252:1998;639-642.
35. Stahl S., Chun T.Y., Gray W.G. Toxicol. Appl. Pharmacol. 152:1998;41-48.
36. Yu S.M., Hung L.M., Lin C.C. Circulation. 95:1997;1269-1277.
37. Kojda G., Hüsgen B., Hacker A., Perings D., Schnaith E.M., Kottenberg E. Cardiovasc. Res. 37:1998;738-747.
38. Brooks, D.P., Jorkasky, D.K., Freed, M.I. and Ohlstein, E.H. (1998) in: Endothelin (Highsmith, R.F., Ed.), pp. 223-268, Humana Press, Totowa, NJ.
39. El-Mowafy A.M., Abdel-Latif A. J. Pharmacol. Exp. Ther. 268:1994;1343-1351.
40. Force, T. (1998) in: Endothelin (Highsmith, R.F., Ed.), pp. 121-166, Humana Press, Totowa, NJ.
41. Inoue R., Waniishi Y., Yamada K., Ito Y. Biochem. Biophys. Res. Commun. 203:1994;1392-1397.
42. Di Salvo J., Nelson S.R., Kaplan N. Proc. Soc. Exp. Biol. Med. 214:1997;285-301.
43. Jayatilake G.S., Jayasuriya H., Lee E.S., Koonchanok N.M., Gealhlen R.L., Ashendel C.L., Mclaughlin J.L., Chang C.J. J. Nat. Prod. 56:1993;1805-1810.
44. Bertelli A., Bertelli A.A.E., Gozzini A., Giovannini L. Drugs Exp. Clin. Res. 24:1998;133-138.